This 2-hour on-demand course and 1-hour live-virtual discussion provides a comprehensive foundation in the reprogramming of somatic cells into induced pluripotent stem cells (iPSCs), a crucial technique in regenerative medicine and cell therapy. Designed by leading academic and industry experts, the course blends self-paced modules with interactive live-virtual discussions, offering both theoretical insights and practical guidance. You will explore the entire reprogramming process, from the key steps involved to the specific workflow considerations based on the starting material. Gain an in-depth understanding of both viral and non-viral reprogramming methods and learn to distinguish between undifferentiated and differentiated iPSC colonies. The course also covers essential assays to evaluate iPSC quality and their readiness for therapeutic use.
Course Content
Learning Outcomes
Designed For
Eligibility
Pricing
The Resource Hub provides supporting materials to help reinforce learning before, during, and after the course.
Webinar title placeholder
This course is structured into the following modules:
Researchers, lab professionals, and process development engineers with cell culture experience who are seeking to master best practices for culturing iPSCs and applying them in cell therapy manufacturing.
Group Registration Discount:
1 Contact ISCT Head Office for Academic pricing codes.
2 Tier 1 & Tier 2 countries listed here.
Shin Kawamata, MD, PhD
CEO, Cyto-Facto (Japan)
“To unlock the full clinical potential of iPSCs, it’s critical to understand not just their biology, but also how to maintain them properly, scale them up efficiently, and apply best practices across the entire workflow. This course brings all those elements together for CGT professionals aiming to translate iPSC-based therapies into the clinic.”
Lise Munsie, PhD
VP, Process Development, BlueRock (USA)
“Maintaining iPSC quality starts with understanding the fundamentals, from colony morphology to genomic stability. This training gives learners the confidence to navigate the complexity of iPSC systems with clarity and scientific rigor.”
Bruno Marques, PhD
VP, Technical Development, Century (USA)
“Establishing a robust and scalable iPSC process requires more than just technical skill, it demands a clear understanding of regulatory expectations and clinical readiness. This course provides that foundation, giving participants a real-world view of what it takes to bring iPSC-based products to patients.”
Note: Completing all training modules and passing the quizzes is mandatory to receive a course completion certificate.
“The speakers delivered the material in a clear and well-structured way, making complex iPSC concepts easy to follow. I especially appreciated how the sessions connected theory to real research applications and clinical translation.”
“Great speakers with diverse backgrounds from both academia and industry. The discussions on challenges of bringing iPSC therapies to clinical trials were particularly valuable and provided practical insight I can apply to my own work.”
“The webinar content was relevant, informative, and directly applicable to my field. It strengthened my confidence in implementing what I learned and I would recommend this training to colleagues interested in cell therapy manufacturing and applications.”
Get in touch with our team to learn more about training programs, partnerships, and opportunities.Institute of Training and Development Privacy & Public Policies